Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Drug-resistant Epilepsy”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableStudy completedNCT04924933
What this trial is testing

Evaluation of Memory and Forgetting in Patients With Epilepsy

Who this might be right for
Epilepsy
Hospices Civils de Lyon 83
Not applicableLooking for participantsNCT03644732
What this trial is testing

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

Who this might be right for
Refractory EpilepsyFocal Epilepsy
University Hospital, Grenoble 200
Not applicableLooking for participantsNCT05947656
What this trial is testing

Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Who this might be right for
Epilepsy, Temporal LobeDrug Resistant Epilepsy
Genovate-NaviFUS (Australia) Pty Ltd. 18
Not applicableLooking for participantsNCT06248333
What this trial is testing

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

Who this might be right for
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing 33
Not applicableUnknownNCT04383028
What this trial is testing

MELD as an Adjunct for SEEG Trajectories

Who this might be right for
EpilepsyEpilepsy, FocalEpilepsy, Refractory
Great Ormond Street Hospital for Children NHS Foundation Trust 20
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Not applicableActive Not RecruitingNCT06681480
What this trial is testing

Transcranial Magnetic Stimulation (rTMS) for Refractory Focal Epilepsy

Who this might be right for
Focal EpilepsyTranscranial Magnetis Stimulation
Comenius University 20
Not applicableUnknownNCT03321240
What this trial is testing

Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia

Who this might be right for
Refractory EpilepsyFocal EpilepsyFocal Cortical Dysplasia
University Hospital, Strasbourg, France 240
Early research (Phase 1)UnknownNCT05198882
What this trial is testing

Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy

Who this might be right for
Drug-resistant Focal EpilepsyEpilepsyEpilepsies, Focal+2 more
Assistance Publique - Hôpitaux de Paris 13
Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20
Not applicableLooking for participantsNCT05339438
What this trial is testing

Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients

Who this might be right for
Epilepsy, Temporal LobeCognitive Decline
Central Hospital, Nancy, France 30
Large-scale testing (Phase 3)Study completedNCT00319501
What this trial is testing

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Who this might be right for
SeizuresEpilepsies, PartialEpilepsy, Complex Partial+2 more
Pfizer 234
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)Study completedNCT00235755
What this trial is testing

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 539
Not applicableLooking for participantsNCT03268824
What this trial is testing

Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain

Who this might be right for
Epilepsies, FocalPediatricsDrug Resistant Epilepsy
Fondation Ophtalmologique Adolphe de Rothschild 82
Not applicableStudy completedNCT03278210
What this trial is testing

National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug

Who this might be right for
Epilepsy IntractableFocal Epilepsy
University Hospital, Lille 102
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Not applicableLooking for participantsNCT06212609
What this trial is testing

Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies

Who this might be right for
Transcranial Electric StimulationtDCSEpilepsy+3 more
Centre Hospitalier Universitaire, Amiens 20
Large-scale testing (Phase 3)Ended earlyNCT01648101
What this trial is testing

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline 76
Not applicableEnded earlyNCT03955432
What this trial is testing

Long-term Cardiac Monitoring in Epilepsy

Who this might be right for
Focal EpilepsyIntractable EpilepsyEpileptic Encephalopathy+3 more
Northwell Health 7
Load More Results